Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | AOAH |
| Upstream (Parents) |
|---|
| (<<) AIF1 → AOAH |
| (<<) CLEC2B → AOAH |
| (<<) LILRA6///LILRB3 → AOAH |
| Downstream (Children) |
|---|
| AOAH → CALML4 (>>) |
| AOAH → FYB (>>) |
| AOAH → CCL3L3///CCL3L1///CCL3 (>>) |
| AOAH → ADCK2 (>>) |
| AOAH → CD180 (>>) |
| AOAH → ADAM28 (>>) |
| AOAH → SIGLEC1 (>>) |
| AOAH → MGC29506 (>>) |
| AOAH → HGF (>>) |
| AOAH → ARSD (>>) |
| AOAH → SLC2A6 (>>) |
| AOAH → MAP4K1 (>>) |
| AOAH → IKZF1 (>>) |
| AOAH → LILRB2 (>>) |
| AOAH → RASGRP3 (>>) |
| AOAH → TNFRSF4 (>>) |
| AOAH → HYDIN (>>) |
| AOAH → KCND1 (>>) |
| AOAH → CD22 (>>) |
| AOAH → PPM1E (>>) |
| AOAH → NOD2 (>>) |
| AOAH → ITGAX (>>) |
| AOAH → TRPC2 (>>) |
| AOAH → CD72 (>>) |
| AOAH → GIT2 (>>) |
| AOAH → ARID5A (>>) |
| AOAH → SFTPC (>>) |
